NEW YORK (GenomeWeb) – Biodesix today announced that Health Net has issued a positive coverage decision for the VeriStrat test. 

According to Biodesix, Health Net considers the test medically necessary for patients with advanced non-small cell lung cancer and wild-type EGFR or with unknown EGFR status. Health Net covers about 5.9 million lives, primarily on the US West Coast. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.